替扎尼定联合文拉法辛缓释片治疗紧张性头痛疗效分析.docVIP

替扎尼定联合文拉法辛缓释片治疗紧张性头痛疗效分析.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
替扎尼定联合文拉法辛缓释片治疗紧张性头痛疗效分析

替扎尼定联合文拉法辛缓释片治疗紧张性头痛疗效分析   [摘要] 目的 探讨替扎尼定联合文拉法辛缓释片治疗紧张性头痛的临床疗效。 方法 选取在我院神经科住院治疗的98例临床确诊的紧张性头痛患者,随机分为治疗组和对照组,每组49例,治疗组采用替扎尼定联合文拉法辛缓释片治疗,对照组采用替扎尼定治疗,两组均于治疗前、治疗后第2周、第4周分别采用视觉模拟评分法(VAS)记录疼痛分值,且于治疗结束前及治疗后用生活质量核心量表(QLQ-C30)对患者生活质量改善情况进行评定。 结果 治疗前治疗组及对照组VAS、QLQ-C30评分比较差异无统计学意义(P0.05)。治疗后第2周、第4周VAS评分与治疗前相比,结果示治疗组、对照组VAS评分差异均有统计学意义(P0.05),但治疗组VAS评分改善明显优于对照组,差异有统计学意义(P0.05)。治疗后第4周治疗组、对照组QLQ-C30评分与治疗前比较,差异有统计学意义(P0.05),但治疗组QLQ-C30评分改善优于对照组,差异有统计学意义(P0.05)。 结论 替扎尼定联合文拉法辛缓释片治疗紧张性头痛安全、可靠,值得临床推荐。   [关键词] 紧张性头痛;文拉法辛缓释片;替扎尼定;视觉模拟评分;生活质量核心量表   [中图分类号] R741 [文献标识码] B [文章编号] 1673-9701(2015)30-0082-03   Effectiveness of combination tizanidine tablets and venlafaxine slow release tablets in tension-type headache   SONG Wanzhi   Department of Neurology, Jiaozuo Tongren Hospital in Henan Province, Jiaozuo 454000, China   [Abstract] Objective To investigate the effect of tizanidine tablets and venlafaxine slow release tablets in treatment of tension-type headache. Methods A total of 98 patients with tension-type headache were randomly divided into the treatment group (n=49, treated with tizanidine tablets and venlafaxine slow release tablets) and the contral group (n=49, treated with tizanidine tablets). The time of two groups were 4 weeks for a course of treatment. Visual analog scale (VAS) were measured before and after treatment 2 weeks, 4 weeks, quality of life questionnaire core-30 scores (QLQ-C30) were measured before and after treatment. Results The VAS, QLQ-C30 scores of two groups had no significant difference before treatment (P0.05). The score of VAS in treatment groups and contral group after 2 weeks, 4 weeks treatment showed statistically significant differences compared with before treatment(P0.05), but the score of VAS in the treatment group patients were significantly greater than the control group (P0.05), which had a statistical significance. The score of QLQ-C30 in treatment groups and control group after 4 weeks treatment showed statistically significant differen

文档评论(0)

317960162 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档